Vitrafy Life Sciences Limited (ASX:VFY)

Vitrafy Life Sciences Revenue

In the fiscal year ending June 30, 2026, Vitrafy Life Sciences had annual revenue of 209.00K AUD, down -80.05%. Vitrafy Life Sciences had revenue of -1.77M in the half year ending June 30, 2026. That makes Vitrafy Life Sciences the 45,768th largest company in the world by revenue and 1,195th in Australia.

• Revenue: 209.00K
• Revenue Growth: -80.05%
• P/S Ratio: 889.61
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 183.64M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	209.00K	-838.75K	-80.05%
Jun 30, 2025	1.05M	-1.05M	-49.95%
Jun 30, 2024	2.09M	37.10K	1.80%
Jun 30, 2023	2.06M	230.64K	12.63%
Jun 30, 2022	1.83M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 2, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 27, 2026

Data Sources Report a data error